| The E3 ubiquitin ligase Itch regulates tumor suppressor protein RASSF5/NORE1 stability in an acetylation-dependent manner R Suryaraja, M Anitha, K Anbarasu, G Kumari, S Mahalingam Cell death & disease 4 (3), e565-e565, 2013 | 51 | 2013 |
| Nimbolide upregulates RECK by targeting miR-21 and HIF-1α in cell lines and in a hamster oral carcinogenesis model J Kowshik, R Mishra, J Sophia, S Rautray, K Anbarasu, GD Reddy, M Dixit, ... Scientific Reports 7 (1), 2045, 2017 | 50 | 2017 |
| BET bromodomain inhibition blocks an AR-repressed, E2F1-activated treatment-emergent neuroendocrine prostate cancer lineage plasticity program DH Kim, D Sun, WK Storck, K Welker Leng, C Jenkins, DJ Coleman, ... Clinical Cancer Research 27 (17), 4923-4936, 2021 | 48 | 2021 |
| Recent advances in epigenetic biomarkers and epigenetic targeting in prostate cancer A Kumaraswamy, KRW Leng, TC Westbrook, JA Yates, SG Zhao, ... European urology 80 (1), 71-81, 2021 | 39 | 2021 |
| Understanding drug sensitivity and tackling resistance in cancer JW Tyner, F Haderk, A Kumaraswamy, LB Baughn, B Van Ness, S Liu, ... Cancer research 82 (8), 1448-1460, 2022 | 32 | 2022 |
| Leucine Zipper Down-regulated in Cancer-1 (LDOC1) interacts with Guanine nucleotide binding protein-like 3-like (GNL3L) to modulate Nuclear Factor-kappa B (NF-κB) signaling … IJ Thoompumkal, K Rehna, K Anbarasu, S Mahalingam Cell Cycle 15 (23), 3251-3267, 2016 | 30 | 2016 |
| Global quantitative proteomics reveal deregulation of cytoskeletal and apoptotic signalling proteins in oral tongue squamous cell carcinoma S Ananthi, CNP Lakshmi, P Atmika, K Anbarasu, S Mahalingam Scientific Reports 8 (1), 1567, 2018 | 26 | 2018 |
| Alternative splicing of LSD1+ 8a in neuroendocrine prostate cancer is mediated by SRRM4 DJ Coleman, DA Sampson, A Sehrawat, A Kumaraswamy, D Sun, ... Neoplasia 22 (6), 253-262, 2020 | 25 | 2020 |
| Nucleolar GTP-binding protein-1 (NGP-1) promotes G1 to S phase transition by activating cyclin-dependent kinase inhibitor p21Cip1/Waf1 D Datta, K Anbarasu, S Rajabather, RS Priya, P Desai, S Mahalingam Journal of Biological Chemistry 290 (35), 21536-21552, 2015 | 22 | 2015 |
| GNL3L is a Nucleo-Cytoplasmic shuttling Protein: Role in cell cycle regulation IJ Thoompumkal, MRK Subba Rao, A Kumaraswamy, R Krishnan, ... PLoS one 10 (8), e0135845, 2015 | 16 | 2015 |
| Subcellular distribution of the human putative nucleolar GTPase GNL1 is regulated by a novel arginine/lysine-rich domain and a GTP binding domain in a cell cycle-dependent manner N Boddapati, K Anbarasu, R Suryaraja, AV Tendulkar, S Mahalingam Journal of molecular biology 416 (3), 346-366, 2012 | 16 | 2012 |
| The non-enzymatic RAS effector RASSF7 inhibits oncogenic c-Myc function A Kumaraswamy, A Mamidi, P Desai, A Sivagnanam, LR Perumalsamy, ... Journal of Biological Chemistry 293 (40), 15691-15705, 2018 | 11 | 2018 |
| LSD1 promotes prostate cancer reprogramming by repressing TP53 signaling independently of its demethylase function A Kumaraswamy, Z Duan, D Flores, C Zhang, A Sehrawat, YM Hu, ... JCI insight 8 (15), 2023 | 5 | 2023 |
| Proteome-wide approach to identify novel biomarkers in oral tumorigenesis S Ananthi, NPL CH, A K, M Sundarasamy Cancer Research 76 (14_Supplement), 3875-3875, 2016 | | 2016 |
| GNL3L is nucleo-cytoplasmic shuttling protein: role in cell division cycle regulation T Jose, MR Rao, A Kumaraswamy, R Krishnan, R Vijayakumaran, ... FEBS JOURNAL 281, 71-72, 2014 | | 2014 |
Rehna KrishnanPrincess Margaret Cancer Research Centre, University Health Network在 uhnresearch.ca 的电子邮件经过验证
